Bethany Samuelson Bannow Welcomed to Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic
Jame Abraham, Chairman and Professor, Department of Hematology and Medical Oncology at Cleveland Clinic, shared on LinkedIn:
”We are thrilled to welcome Dr, Bethany Samuelson Bannow as the Program Leader of Classical Hematology in the Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic
Dr. Samuelson Bannow earned her medical degree from Oregon Health and Science University completed her residency at the University of California, San Francisco, and her fellowship at the University of Washington.
She has served as an Acting Instructor at the University of Washington and later as Assistant Professor and Associate Professor in Hematology and Oncology at OHSU.
A hematologist, scientist, and educator, Dr. Samuelson Bannow is passionate about advancing the care of patients with bleeding and clotting disorders.
She has led and participated in multiple clinical trials focused on hemophilia, von Willebrand disease, and other bleeding disorders, and her research centers on blood clotting regulation and women’s health in hematology.
She is also actively engaged in professional leadership, serving as Associate Editor of ASH Clinical News, Co-Chair of the Thrombosis Subcommittee of the Foundation for Women and Girls
With Blood Disorders, and on committees for the Hemostasis and Thrombosis Research Society and the American Board of Internal Medicine American Society of Hematology.”
Stay updated with Hemostasis Today.
-
Feb 16, 2026, 13:56Chokri Ben Lamine: Evans Syndrome Key Clinical Insights
-
Feb 16, 2026, 13:51Adela Castro: 2025 EULAR Guidelines Key Updates in Lupus Nephritis
-
Feb 16, 2026, 13:50Rosa Hart: Stop Waiting For A Seat And Start Shaping The Table
-
Feb 16, 2026, 13:49Harprit Singh: India’s Silent Transfusion Gap – What Policymakers Need to Know in 2026
-
Feb 16, 2026, 13:46A Conversation on Gene Therapy in Hemophilia B – Irish Haemophilia Society
-
Feb 16, 2026, 13:45Nathan Connell Speaks on Gender Diversity In Haemostasis Care at EAHAD 2026
-
Feb 16, 2026, 13:40David McIntosh: Concrete Performance Targets for Rare Disease Patients
-
Feb 16, 2026, 13:40Ramy Abdelnaby: Exploring The Timing of Antiplatelet Administration In Minor Stroke Post-Thrombolysis
-
Feb 16, 2026, 13:33Anne Hege Aamodt Congratulates Gisle Berg Helland on PhD Defense About Stroke Outcome MRI and ML Prediction